Miyawaki, T., Ohde, Y., Doi, H., Oshima, M., Sakamaki, K., Shinno, Y., Masuda, K., Ito, K., Kaira, K., Okishio, K., Furuya, N., Ninomiya, K., Tanaka, Y., Takenaka, M., Tanaka, I., Furuta, M., Harada, H., Yamamoto, N., Kenmotsu, H. (2026). Phase III study of multidisciplinary therapy combining local ablative therapy with immune-checkpoint inhibitors for patients with synchronous oligometastatic NSCLC (J-OLIGO: WJOG20924L).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps8667